DarrellMealerWilsonMD

PubMed

• 3 citations
  Diabetic Ketoacidosis at Diagnosis in Youth with Type 1 Diabetes Is Associated with a Higher Hemoglobin A1c Even with Intensive Insulin Management.
  Dessi P Zaharieva, Victoria Y Ding, Ananta Addala, Priya Prahalad, Franziska Bishop
  Diabetes Technology & Therapeutics. 2024-03-01
• 11 citations
  OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals.
  Alyssa Ylescupidez, Cate Speake, Susan L Pietropaolo, Darrell M Wilson, Andrea K Steck
  The Journal of Clinical Endocrinology and Metabolism. 2023-12-21
• 13 citations
  CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.
  Darrell M Wilson, Susan L Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Destiny Anyaiwe
  Diabetes Care. 2023-03-01

Journal Articles

• Reactivation of Latent Viruses in Individuals Receiving Rituximab for New Onset Type 1 Diabetes  
  Kroll JL, Beam C, Li S, Viscidi R, Pescovitz M, Weinberg A, the Type 1 Diabetes TrialNet Anti CD-20 Study Group, J Clin Virol, 2/17/2013
• Epstein Barr and other Herpes Virus Infections in Early Onset Type I Diabetics Treated with Daclizumab and Mycophenolate Mofetil  
  Loechelt BJ, Boulware D, Green M, Baden LR, Gottlieb P, Krause-Steinrauf H, Weinberg A; for the Type I Diabetes TrialNet Daclizumab/Mycophenolic Acid Study Group, Clin Infect Dis, 10/5/2012
• The Landmark JDRF Continuous Glucose Monitoring Randomized Trials: a Look Back at the Accumulated Evidence  
  Ruedy KJ, Tamborlane WV, for the Juvenile Diabetes Research Foundation The Landmark JDRF Continuous Glucose Monitoring Study Group, J of Cardiovasc Trans Res, 8/1/2012
• Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High Risk Population - Receiver Operating Characteristic Analysis  
  Xu P, Beam CA, Cuthbertson D, Sosenko JM, Skyler JS, Krischer JP and the DPT-1 Study Group, Diabetes Care, 7/11/2012
• The Application of the Diabetes Prevention Trial–Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes  
  Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP, The Type 1 Diabetes TrialNet And Diabete..., Diabetes Care, 7/1/2012
• Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes  
  Tsalikian E, Fox L, Weinzimer S, Buckingham B,, White NH, Beck R, Kollman C, Xing D, Ruedy K and the Diabetes Research in Children, Pediatric Diabetes, 6/1/2012
• Achievement of Target A1c Levels with Negligible Hypoglycemia and Low Glucose Variability in Youth with Short-Term Type 1 Diabetes and Residual beta-cell function  
  Sherr J, Tamborlane WV, Xing D, Tsalikian E, Mauras N, Buckingham B, White NH, Arbelaez AM, Beck RW, Kollman C, Ruedy K, On Behalf Of The Diabetes Research In Children..., Diabetes Care, 4/1/2012
• Rituximab Selectively Suppresses Specific Islet Antibodies  
  Yu L, Herold K, Lachin J, Bundy B, Pugliese A, Krischer J, Eisenbarth G, Pescovitz M, Type 1 Diabetes TrialNet Anti-CD20 Study Group, Diabetes, 1/1/2012
• Fall in C-peptide Over First Two Years from Diagnosis: Evidence of At Least Two Distinct Phases from Composite TrialNet Data  
  Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC, Lachin JM, McGee P, Palmer JP, Pescovitz MD, Krause-Steinrauf H, Skyler JS, Sosenko JM, Type 1 ..., Diabetes, 1/1/2012
• Performance of Glycated Hemoglobin (HbA1c) as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth  
  Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers M, Schatz DA, Krischer JP, and the TEDDY, TRIGR, Diabetes Prevention Trial-Typ..., Diabetes Care, 1/1/2012
• A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 ...  
  Mauras, N Beck R, Xing D, Ruedy K, Buckingham B, Tansey M, White NH, Weinzimer SA, Tamborlane W, Kollman C and the Diabetes Research In Children Network (DirecNet) Stu..., Diabetes Care, 12/30/2011
• Effect of Rituximab on Human In Vivo Antibody Immune Responses  
  Pescovitz MD, Torgerson TR, Ochs HD, Ocheltree E, McGee P, Krause-Steinrauf H, Lachin JM, Canniff J, Greenbaum C Herold KC, Skyler JS, Weinberg A and the Type 1 Diabet..., J Allergy Clin Immunol, 12/1/2011
• Comparison of Two Insulin Assays for First-Phase Insulin Release in Type 1 Diabetes Prediction and Prevention Studies  
  Mahon JL, Beam CA, Marcovina SM, Boulware DC, Palmer UP, Winter William E, Skyler JS, Krischer JP and the Type 1 Diabetes TrialNet Study Group, Clinica Chimica Acta, 11/20/2011
• A Longitudinal Study of GAD65 and ICA512 Autoantibodies during the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) Participants  
  Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Cuthbertson D, Yu L, Schatz DA, Orban T, Eisenbarth G, Diabetes Prevention Trial-Type 1 and Type 1 Diabetes TrialNet Stu..., Diabetes Care, 11/1/2011
• Development of Autoantibodies in the TrialNet Natural History Study (NHS)  
  Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, Skyler JS, Krischer JP for the TrialNet Natural History Study Group, Diabetes Care, 9/1/2011
• Increased T Cellular Proliferative Responses to Islet Antigens Identify Clinical Responders to Anti-CD20 Monoclonal Antibody (Rituximab) Therapy in Type 1 Diabetes  
  Herold K, Pescovitz M, McGee P, Krause-Steinrauf H, Spain L, Bourcier K, Asare A, Liu Z, Lachin J, Dosch HM, for the Type 1 Diabetes TrialNet Study Group, J Immunology, J Immunol, 8/15/2011
• Long-Term Outcome of Individuals Treated With Oral Insulin  
  Vehik K, Cuthbertson D, Ruhlig H, Schatz DA, Peakman M, Krischer JP For The DPT-1 And TrialNet Study Group, Diabetes Care, 7/1/2011
• Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study  
  Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP; the TrialNet and Diabetes Prevention Tri..., Diabetes Care, 6/16/2011
• Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for Repeat Screening Throughout Childhood  
  Vehik K, Haller MJ, Beam CA, Schatz DA, Wherrett DK, Sosenko JM, Krischer J, the DPT 1 Study Group, Diabetes Care, 1/1/2011
• Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes  
  Tansey M. Laffel L, Cheng J, Beck R, Coffey J, Huang E, Kollman C, Lawrence J, Lee J, Ruedy K, Tamborlane W, Wysocki T, Xing D on behalf of Juvenile Diabetes Research ..., Diabet. Med, 1/1/2011
• Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Diabetes  
  Lachin JM, McGee PL, Greenbaum CJ, Palmer J, Pescovitz MD, Gottlieb P, Skyler J for the Type 1 Diabetes TrialNet Study Group, PLOS One, 1/1/2011
• Insulin Pump Use and Its Efficacy in Preschool Aged Children  
  Fuld K, Conrad B, Buckingham BA, Wilson DM, Diabetes Technology & Therapeutics, 6/1/2010
• The cost-effectiveness of continuous glucose monitoring in type 1 diabetes  
  Huang ES, O'Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T; Juvenile Diabetes Research Foundation Continu..., Diabetes Care, 6/1/2010
• Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Non-diabetic Individuals  
  The Juvenile Diabetes Research Foundation CGM Study Group,, Care, 6/1/2010
• A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants  
  Sosenko JM, Mahon J, Rafkin L, Lachin JM, Krause-Steinrauf H, Krischer JP, Cuthbertson D, Palmer JP, Thompson C, Greenbaum CJ, Skyler JS; Diabetes Prevention Trial-Typ..., Pediatr Diabetes, 5/26/2010
• Join now to see all

Books/Book Chapters

• A Practical Guide to Pediatric Emergency Medicine 
  Chapter: Neonatal emergencies, Chapter 157 
  Park JG, N. Amieva-Wang E, Turchi C, Forghani N, and Wilson DMEditors: Amieva-Wang et al.Cambridge Press2011
• Endocrine disorders 
  Chapter: A Practical Guide to Pediatric Emergency Medicine 
  Forghani N, Wilson DMEditors: Amieva-Wang et al.Cambridge Press2011
• Real-time continuous glucose monitoring 
  Buckingham B, Caswell K, Wilson DM2007
• Contemporary Endocrinology: Hormone Replacement Therapy in Clinical Practice 
  Chapter: Growth hormone therapy in children and adult 
  Wilson DMEditors: Meikle AW.Humana Press Inc., Toronto, NJ2003
• Contemporary Endocrinology: Hormone Replacement Therapy 
  Chapter: Growth hormone therapy in children 
  Lum CK, Wilson DMEditors: Meikle AW.Humana Press Inc., Toronto, NJ1999
• UPDATE #8 - Nelson's Textbook of Pediatrics 
  Chapter: Diabetes Mellitus in Children and Adolescents 
  Wilson DM1995
• Frontiers in Rehabilitation Medicine: Osteogenesis Imperfecta, Connective Tissue Research 
  Chapter: Endocrinology of growth and growth factors 
  Wilson DMEditors: Gerber L, Byers P, Marini J.1995
• Nelson Self-Assessment Program 
  Chapter: Diabetes mellitus 
  Wilson DMEditors: Prober CG, Behrman RE, Cisco J.WB Saunders1995
• Puberty... When it comes too soon. A Special Ross Round table on Pediatric Research, Conference in Washington, DC 
  Chapter: Indications for Treatment 
  Hintz RL, Wilson DMEditors: Hintz RL, Wilson DM.Ross Products Division, Abbott Laboratories, Columbus, OH1994
• Fundamentals of Pediatrics 
  Chapter: Pediatric Endocrinology 
  Rosenthal S, Wilson DMEditors: Appleton & Lange.Norwalk, CT1994
• Phosphate in Pediatric Health and Disease 
  Chapter: Renal hypophosphatemia 
  Page 159 - 192Wilson DM, Alon UEditors: Alon U, Chan JCM.CRC Press, Boca Raton, FL1993
• Endocrinology and Metabolism Clinics of North America 
  Chapter: Clinical Actions of Growth Hormone 
  Page 519 - 537Wilson DM1992
• Turner syndrome 
  Chapter: Effects of growth hormone and oxandrolone therapy on carbohydrate metabolism in Turner syndrome 
  Page 433 - 445Wilson DM, Hintz RL, Rosenfeld RG, Frane JW, Sherman B, Johanson AJEditors: Rosenfeld RG, Grumbach M.Marcel Dekker, Inc, NY1990
• Advances in Endocrinology and Metabolism 
  Chapter: New directions in the diagnosis and treatment of growth failure 
  Page 95 - 128Wilson DM, Rosenfeld RGEditors: Mazzaferri E, Bar RS, Kreisberg RA.1990
• Highlights of the 3rd International Symposium on Endocrine Disorders 
  Chapter: Hypophosphatemic rickets 
  Page 16 - 17Wilson DMEditors: Rosenfeld RG.Excerpta Medica1990
• Insulin-like Growth Factor Binding Proteins 
  Chapter: IGFs and IGF binding proteins in human breast cancer cell lines 
  Page 241 - 246Wilson DM, DeLeon DD, Bakker B, Lamson G, Rosenfeld RGEditors: Hintz RL.Elsevier Science Publishers, Amsterdam1989
• Insulin-like Growth Factor Binding Proteins 
  Chapter: Serum levels of 25Kda insulin-like growth factor binding in children with insulin-dependent diabetes mellitus 
  Page 39 - 44Wang M, Wilson DM, Lee PDKEditors: Hintz RL.Elsevier Science Publishers, Amsterdam1989
• Disorders of Human Growth: Advances in Research and Treatment 
  Chapter: Use of somatomedin assays in the evaluation of short stature. NICHD International Workshop on Advances in Research of Human Growth 
  Page 82 - 95Rosenfeld RG, Wilson DM, Lee PDK, Hintz RLEditors: Grave GD, Cassorla FG.Thomas, Springfield, IL1988
• Acromegaly 
  Chapter: Somatomedin action and tissue growth factor receptors 
  Page 55 - 64Rosenfeld RG, Ceda GP, Conover CA, Wilson DM, Hoffman AREditors: Robbins R, Melmed S.Plenum Press, NY1987
• Future Clinical Use of Growth Hormone, Series Pediatric and Adolescent Endocrinology 
  Chapter: Usefulness of somatomedin C/Insulin-like growth factor levels and response in growth hormone deficiency 
  Page 29 - 36Hintz RL, Wilson DM, Rosenfeld RGEditors: Laron Z, Butenandt O.S Karger1987
• Slow Grows the Child: Psychosocial Aspects of Growth Delay 
  Chapter: The effects of growth on intellectual function in children and adolescents 
  Page 139 - 150Wilson DM, Duncan PM, Dornbusch SM, Ritter PL, Rosenfeld RGEditors: Stabler B, Underwood LE.Lawrence Erlbaum Associates, NJ1986
• Somatomedins and Other Peptides Growth Factors: Relevance to Pediatrics 
  Chapter: Clinical relevance of the somatomedins 
  Page 64 - 69Rosenfeld RG, Wilson DM, Lee PDK, Hintz RLEditors: Hintz RL, Underwood LE.Ross Laboratories1985
• Hormone Drug Proceedings of the FDA USP Workshop on Drug and Reference Standards for Insulins, Somatotropins, and Thyroid axis Drugs 
  Chapter: Recombinant DNA derived growth hormone is biologically active in humans: In vitro and in vivo studies 
  Page 352 - 362Rosenfeld RG, Wilson DM, Bennett A, Hintz RLEditors: JL Guerigan, ED Branson, AS Outschoorn.USPC, Rockville, MD1982
• Growth Abnormalities, Contemporary Issues in Endocrinology and Metabolism 
  Chapter: Growth abnormalities in diabetes mellitus 
  Page 59 - 80Wilson DMEditors: Hintz RL, Rosenfeld RG.Churchill Livingstone, Inc
• Join now to see all

Abstracts/Posters

• Glucose simulators: Ready for Prime Time? (editorial)
  Wilson DM, Diabetes Technology & the 2013 American Control Conference, Therapeutics, Washington, DC, USA, 1/1/1999

Other

• The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes 
  DirecNet (Wilson DM)
  1/1/2007
• Book review JAMA, Preventing Childhood Obesity: Health in the Balance 
  Wilson DM
  1/1/2006
• Book review. Diabetes,: Nestle Nutrition Workshop Series 
  Wilson DM
  1/1/1996
• Abnormal growth patterns in children 
  Wilson DM, Rosenfeld RG
  3/1/1988
• Therapeutic goals in children with diabetes 
  Wilson DM
  4/1/1987
• Join now to see all